Literature DB >> 11168995

Role of oxidized low-density lipoprotein in the atherosclerosis of uremia.

T B Drüeke1, T Nguyen Khoa, Z A Massy, V Witko-Sarsat, B Lacour, B Descamps-Latscha.   

Abstract

Lipoprotein oxidation is involved in the genesis of atherosclerosis. In chronic renal failure (CRF), oxidative stress is enhanced because of an imbalance between pro-oxidant and antioxidant systems. Oxidative modifications of low-density lipoproteins (LDLs) occur not only at the level of lipid moiety, but also of protein moiety. We have shown that oxidation of LDL by hypochlorous acid (HOCl) in vitro, reflecting increased myeloperoxidase activity in vivo, leads to modifications of apoliproteins such that the latter in turn are capable of triggering macrophage nicotinamide adenine dinucleotide phosphate-oxidase activation. These oxidative changes of LDL protein moiety, if shown to occur to a significant extent in uremic patients in vivo, may represent an important alternative pathway in the pathogenesis of atheromatous lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168995     DOI: 10.1046/j.1523-1755.2001.59780114.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  7 in total

Review 1.  Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials.

Authors:  S Saboori; S Shab-Bidar; J R Speakman; E Yousefi Rad; K Djafarian
Journal:  Eur J Clin Nutr       Date:  2015-02-11       Impact factor: 4.016

2.  Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study.

Authors:  Yu-Feng Lin; Chiang-Ting Chien; Wei-Chih Kan; Yung-Ming Chen; Tzong-Shinn Chu; Kuan-Yu Hung; Tun-Jun Tsai; Kwan-Dun Wu; Ming-Shiou Wu
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

3.  Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination.

Authors:  Stéphanie Badiou; Jean-Paul Cristol; Isabelle Jaussent; Nathalie Terrier; Marion Morena; François Maurice; Hélène Leray-Moragues; Jean-Pierre Rivory; Lofti Chalabi; Cécile Delcourt; Bernard Canaud; Anne-Marie Dupuy
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

4.  High prevalence of intracranial artery calcification in stroke patients with CKD: a retrospective study.

Authors:  Jean-Marc Bugnicourt; Jean-Marc Chillon; Ziad A Massy; Sandrine Canaple; Chantal Lamy; Hervé Deramond; Olivier Godefroy
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 8.237

5.  Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice.

Authors:  Cristina Sastre; Alfonso Rubio-Navarro; Irene Buendía; Carmen Gómez-Guerrero; Julia Blanco; Sebastian Mas; Jesús Egido; Luis Miguel Blanco-Colio; Alberto Ortiz; Juan Antonio Moreno
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 6.  Icosapent ethyl for the treatment of severe hypertriglyceridemia.

Authors:  Hassan Fares; Carl J Lavie; James J DiNicolantonio; James H O'Keefe; Richard V Milani
Journal:  Ther Clin Risk Manag       Date:  2014-06-24       Impact factor: 2.423

Review 7.  Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.

Authors:  Lucas Opazo-Ríos; Sebastián Mas; Gema Marín-Royo; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.